News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Repros Therapeutics (RPRX) Reports Third Quarter 2016 Financial Results



11/9/2016 8:38:15 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
THE WOODLANDS, Texas, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the third quarter ended September 30, 2016.

Financial Results

Net loss for the three month period ended September 30, 2016, was ($4.2) million or ($0.17) per share as compared to a net loss of ($6.6) million or ($0.27) per share for the same period in 2015. The net loss for the nine month period ended September 30, 2016, was ($13.3) million or ($0.55) per share as compared to a net loss of ($22.9) million or ($0.94) per share for the same period in 2015. The decreased loss for both the three and nine month periods was primarily due to decreased clinical development expenses related to the Company’s enclomiphene and Proellex product candidates, as well as decreased payroll and benefits expenses and legal expenses.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES